protein gamma (Gγ) prenylation under suboptimal conditions Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody Activation of PI3K

< GPCR News < GPCRs in Oncology and Immunology Exploiting frequent and specific expression of PRL3 in pediatric solid tumors for first-in-child use of PRL3-zumab humanized antibody Published date September signaling proteins that commonly interacted with PRL3. The first use of PRL3-zumab in a pediatric patient saw no adverse events. clinical application of PRL3-zumab in pediatric patients."